Latest News for: glioblastoma
Edit
Ride Cincinnati grant funds research on immune activating wafer for glioblastoma treatment (University of Cincinnati)
Public Technologies 12 Feb 2026
) Ride Cincinnati grant funds research on immune activating wafer for glioblastoma treatment ... Jonathan Forbes, MD, the project's principal investigator, explained glioblastomas are the most common type of primary cancer of the brain.
Edit
Glioblastoma Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | ...
GetNews 12 Feb 2026
Glioblastoma, also known as glioblastoma multiforme (GBM), is a type of malignant brain tumor that arises from astrocytes, a type of supportive cells in the brain ... Glioblastoma current marketed and Glioblastoma emerging therapies.
Edit
Hastings Tribune
11 Feb 2026
Mass Gen, Dana-Farber researchers find that virus therapy boosts survival in glioblastoma patients
BOSTON — Glioblastoma patients, long shut out from immunotherapies that have transformed patient care in other cancers, could finally benefit from a new treatment option ... .
Edit
Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit
Nasdaq Globe Newswire 11 Feb 2026
... Glioblastoma Drug Development Summit, taking place February 17-19, 2026 in Boston, Massachusetts.
Edit
The Milton Standard Journal
10 Feb 2026
Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February ...
Edit
Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026
Pharmiweb 10 Feb 2026
Edit
Glioblastoma Clinical Trial Pipeline Accelerates as 200+ Pharma Companies Rigorously Develop Drugs for Market Entry ...
GetNews 09 Feb 2026
Inactive Products Glioblastoma Key Companies Glioblastoma Key Products Glioblastoma- Unmet Needs Glioblastoma- Market Drivers and Barriers Glioblastoma- Future Perspectives and Conclusion Glioblastoma ...
Edit
Woman shares survival journey after migraines led to glioblastoma diagnosis
CBS News 07 Feb 2026
Becca Valle thought her headaches were migraines. Brain surgery found a deadly form of cancer ... .
Edit
Cancer Center tests treatment using ‘glioblastoma-on-a-chip’ and wafer technology (University of Cincinnati)
Public Technologies 04 Feb 2026
) Cancer Center tests treatment using 'glioblastoma-on-a-chip' and wafer technology ... Jonathan Forbes, MD, the project's principal investigator, explained glioblastomas are the most common type of primary cancer of the brain.
Edit
Shanghai researchers unveil promising clinical trial results in glioblastoma treatment
China Daily 30 Jan 2026
It marked the first time in the country that such device — an ultrasound-based diagnostic and therapeutic tool — has demonstrated clear clinical efficacy, offering new hope for glioblastoma patients.
Edit
ImmunityBio Reports Median Overall Survival Not Yet Reached and Lymphopenia Reversed in Recurrent Glioblastoma Patients Receiving ANKTIVA® Plus CAR-NK, Chemo-Free Therapy (Immunitybio Inc)
Public Technologies 26 Jan 2026
"Across contemporary studies, median overall survival for patients with recurrent glioblastoma is approximately six to nine months ... About Glioblastoma. Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor in adults.
Edit
The Galveston Daily News
23 Jan 2026
ImmunityBio Reports Median Overall Survival Not Yet Reached and Lymphopenia Reversed in Recurrent Glioblastoma Patients ...
Edit
Adaptin Bio Advances Novel Brain Cancer Treatment Candidate Towards Phase 1 Glioblastoma Clinical Trial
Nasdaq Globe Newswire 20 Jan 2026
The Preston Robert Tisch Brain Tumor Center grants first IRB approval for APTN-101’s Phase I clinical trial, enabling patient recruitment to begin ... .
Edit
Glioblastoma Multiforme Treatment Market to Worth Over US$ 6.1 Billion by 2033 | Astute Analytica
Nasdaq Globe Newswire 19 Jan 2026
Edit
GT Medical Technologies Announces First Patients Treated with GammaTile in the BRIDGES Trial for Newly Diagnosed Glioblastoma
PR Newswire 14 Jan 2026
-According to the American Brain Tumor Association, newly diagnosed glioblastoma is one of the most complex tumors to treat with an average patient survival of less than two years- ... clinical trial for newly diagnosed glioblastoma (GBM).
- 1
- 2
- Next page »